Azenta, Inc. — insider transactions
8 transactions on record · CIK 933974
Aggregates
computed from the filings belowPurchases, 12m
1
count of open-market buys
Sales, 12m
7
count of open-market sales
Buy / sell ratio, 12m
0.14
purchases per sale
Distinct insiders, 12m
6
Bought, 3m
$8.1K
Sold, 3m
$34.8K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$34.8K
2026-08-09
Director share, 12m
0.0%
of transactions where role is stated
Current run
7 sells
consecutive same-direction transactions
Net 3m flow
-$26.7K
purchases minus sales
Total on record
8
Transactions
8 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 | 2026-09-15 | 1 | Bello Erik J. | VP Chief Accounting Officer | Grant or award | 4,586 | $0.00 | — | filing |
| 2026-09-16 | 2026-09-14 | 2 | Lin Lawrence Y. | EVP, CFO and Treasurer | Grant or award | 30,544 | $0.00 | — | filing |
| 2026-09-16 | 2026-09-14 | 2 | MARTIN WILLIAM E. III | President Multiomics | Grant or award | 15,272 | $0.00 | — | filing |
| 2026-09-16 | 2026-09-14 | 2 | Starr Ephraim | Secretary | Grant or award | 15,272 | $0.00 | — | filing |
| 2026-09-16 | 2026-09-14 | 2 | Pirogova Olga | SVP and CHRO | Grant or award | 15,272 | $0.00 | — | filing |
| 2026-09-16 | 2026-09-14 | 2 | Madaus Martin D | Interim CEO | Grant or award | 36,653 | $0.00 | — | filing |
| 2026-08-11 | 2026-08-09 | 2 | Pirogova Olga | SVP and CHRO | Shares withheld for tax | 1,085 | $32.04 | $34.8K | filing |
| 2026-08-04 | 2026-07-31 | 4 | Starr Ephraim | SVP, Gen Counsel & Secretary | Open market purchase | 335 | $24.17 | $8.1K | filing |